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Abstract Caveolins are scaffolding proteins able to collect on
caveolae a large number of signalling proteins bearing a caveolin-
binding motif. The proteins of the striatin family, striatin,
SG2NA, and zinedin, are composed of several conserved,
collinearly aligned, protein^protein association domains, among
which a putative caveolin-binding domain [Castets et al. (2000)
J. Biol. Chem. 275, 19970^19977]. They are associated in part
with membranes. These proteins are mainly expressed within
neurons and thought to act both as scaffolds and as Ca2-
dependent signalling proteins [Bartoli et al. (1999) J. Neurobiol.
40, 234^243]. Here, we show that (1) rat brain striatin, SG2NA
and zinedin co-immunoprecipitate with caveolin-1; (2) all are
pulled down by glutathione-S-transferase (GST)^caveolin-1; (3)
a fragment of recombinant striatin containing the putative
caveolin-binding domain binds GST^caveolin-1. Hence, it is
likely that the proteins of the striatin family are addressed to
membrane microdomains by their binding to caveolin, in
accordance with their putative role in membrane trafficking
[Baillat et al. (2001) Mol. Biol. Cell 12, 663^673]. ß 2001
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Striatin is an intracellular protein of 780 amino acids (aa)
mainly found in the somato-dendritic compartment, including
spines, of a few subsets of neurons [4,5]. It is distributed both
in the cytosol and in the membrane fraction in roughly equal
amounts. Striatin contains several protein^protein association
domains: from the N- to the C-terminus, a putative caveolin-
binding motif, a coiled-coil structure, a Ca2^calmodulin-
binding site and a large WD-repeat domain [4,6]. Hence, stria-
tin is thought to be a sca¡olding protein functioning in a
Ca2-dependent manner. Striatin is a neuronal protein, whose
down-regulation, both in developing motoneurons and in live
rats, has severe e¡ects [2]. Striatin directly interacts with pho-
cein, a protein involved in vesicular tra⁄c [3]. Two other
proteins, SG2NA (including its splice variants), which is an
ubiquitous protein, and zinedin, mainly restricted to the nerv-
ous system, are respectively 80 and 75% similar to striatin,
they share identical protein^protein interaction domains iden-
tically aligned [1]. In particular, the caveolin-binding motifs of
SG2NA and zinedin are 91% identical and 100% similar to
that of striatin. Striatin, SG2NA and zinedin constitute the
striatin family.
Caveolins, integral membrane proteins of 21^25 kDa, are
the main components of caveolae, specialized domains of rafts
[7]. Caveolins have a hairpin topology, with two intracyto-
plasmic domains on both sides of a 33 aa long intramembrane
loop. They are sca¡olding proteins able to interact with spe-
ci¢c lipids and with a great number of signalling proteins:
Ras, serine^threonine kinases, several tyrosine kinases,
G protein-coupled receptors, several G-protein K subunits,
some downstream e¡ectors of G proteins [8]. Caveolins have a
sca¡olding domain of 20 aa long, located in the juxtamem-
branous region of the N-terminal moiety. This domain
binds caveolin-binding motifs of the type xXxXXXXx,
xXXXXxXXx or xXxXXXXxXXx, where x is an aro-
matic residue and X any aa [9]. In some instances, one of
the x is replaced by Leu [10]. Such motifs are present in al-
most all signalling proteins that bind caveolins [11^13].
Caveolae are centers of signal transduction [8]. Typical ca-
veolae have not yet been identi¢ed in neurons, however, micro-
domains containing caveolins-1 and -2 are part of the im-
mensely complex neuronal plasma membrane [14,15]. The
presence of a consensus caveolin-binding domain in the
N-terminal region of striatin (53LHFLQHEWARF63), which
is well conserved in SG2NA and zinedin [1], suggests that the
interaction between these proteins and caveolin is direct. To
clarify this point, we realized co-immunoprecipitation and
pull-down experiments, which indeed show that this inter-
action is direct and functional in vitro. Hence, caveolin-1
may directly regulate the function of the proteins of the
striatin family, by concentrating them within caveolin-en-
riched domains.
2. Materials and methods
Unless otherwise indicated, all experiments took place at 4‡C.
2.1. Subcellular fractionation of rat brain
Adult Wistar rats were anaesthetized and their brain homogenized
(1 g wet weight in 10 ml) in Tris^saline bu¡er (TBS; 50 mM Tris^
HCl, pH 7.4, 150 mM NaCl) containing 1 mM EGTA or 0.1 mM
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CaCl2 and 5 mM MgCl2. The homogenate was centrifuged 1 h at
100 000Ug, yielding a cytosol fraction (1.5 mg protein/ml) and a
100 000Ug pellet. The latter was homogenized in 3-[(3-cholamido-
propyl)-dimethylammonio]-1-propanesulfate (CHAPS)-bu¡er (50
mM Tris^HCl, pH 7.4, 500 mM NaCl, 7.5 mM CHAPS (Sigma, St.
Louis, MO, USA), containing either 1 mM EGTA or 0.1 mM CaCl2
and 5 mM MgCl2) and centrifuged 1 h at 100 000Ug. Supernatants
were called CHAPS fractions (2 mg protein/ml).
2.2. Plasmid constructs
The pGEX-caveolin-1 full length plasmid was a gift of Dr. Andrew
Quest (University of Chile, Santiago, Chile) [16]. The pGEX-P-striatin
1^427 plasmid was constructed by inserting two complementary oli-
gonucleotides (5P-GATCTCTGGAAGTGCTCTTCCAGGGTCCG-
C-3P and 5P-GATCGCGGACCCTGGAAGAGCACTTCCAGA-3P)
encoding the PreScission Protease site (Amersham Pharmacia Biotech,
Piscataway, NJ, USA) into the BamH-1 site of the pGEX-striatin
1^427 plasmid [5]. The sequence of the resulting plasmid was veri¢ed
(ESGS, Evry, France). The pGEX-P-SG2NA-L 1^465 plasmid en-
coded glutathione-S-transferase (GST) fused to the mouse 465 ¢rst
aa of the SG2NA-L isoform (accession number: AF307777) separated
by the PreScission Protease site [1].
2.3. Puri¢cation of recombinant proteins
Expression of the GST fusion proteins in Escherichia coli XL1Blue
strain (Stratagene, La Jolla, CA, USA) was induced by overnight
incubation with 0.1 mM isopropyl L-D-thiogalactoside at 18‡C. Cells
were lysed using a French press. Fusion proteins contained in the
soluble fraction were puri¢ed on glutathione^Sepharose 4B beads
(Amersham Pharmacia Biotech). Beads coated with GST or GST^
caveolin-1 were extensively washed with TBS and used as such. Beads
coated with GST^P-striatin 1^427 or GST^P-SG2NA-L 1^465 were
incubated overnight at 4‡C in TBS containing 1 mM DTT, 1 mM
EDTA and 10 U of PreScission Protease per 50 ml of culture. The
supernatants contained the striatin 1^427 fragment and the SG2NA-L
1^465 fragment, respectively.
2.4. Antibodies
Rabbit anti-caveolin-1 antibodies were from Santa Cruz Biotech
(sc-894, Santa Cruz, CA, USA). Rabbit anti-striatin antibodies were
a⁄nity-puri¢ed anti-peptide antibodies directed against rat striatin aa
267^287 [4]. To obtain rabbit anti-SG2NA antibodies, 200 Wg of pu-
ri¢ed SG2NA-L 1^465 was resolved on 10% sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE) and transferred to
Protran membranes (Schleicher and Schuell, Keene, NH, USA). The
strip containing the puri¢ed protein was blocked at room temperature
for 45 min in TBS containing 5% non-fat dry milk, incubated for 5 h
at room temperature in 40 ml of a 10-fold dilution of anti-SG2NA
serum [1]. The washed strips were incubated for 10 min with 1 ml of
0.1 M glycine^HCl bu¡er, pH 2.5, then with 1 ml of glycine^HCl
bu¡er, pH 2.2. Antibody-containing eluates were neutralized, comple-
mented with 0.1% bovine serum albumin (BSA), concentrated in a
Prodicon apparatus (Bio-Molecular Dynamics, Beaverton, OR,
USA), and aliquots were frozen at 320‡C. Rabbit anti-zinedin anti-
bodies were described [1].
Antibodies were revealed using the enhanced chemoluminescence
(ECL) procedure (Pierce, Rockford, IL, USA) or the alkaline phos-
phatase procedure, depending on the background produced in each
case.
2.5. Co-immunoprecipitation
Co-immunoprecipitation assays were performed as described previ-
ously [3] with slight modi¢cations. Brie£y, 4 ml CHAPS fractions
(diluted to 250 mM NaCl, 7.5 mM CHAPS) were incubated with,
respectively, 140 Wg of rabbit pre-immune immunoglobulins (Sigma),
140 Wg of anti-caveolin-1, 140 Wg of anti-striatin, 140 Wg of anti-
SG2NA and 140 Wg of anti-zinedin antibodies, overnight at 30‡C,
with gentle agitation. Batches of 70 Wl of a 10% suspension of Pan-
sorbin (PS) cells (Calbiochem, San Diego, CA, USA), pre-incubated
in TBS containing 1% BSA, were added to each 4 ml sample and
further incubated for 4 h at 30‡C. PS cells were centrifuged at
12 000Ug and washed ¢ve times in TBS containing 7.5 mM CHAPS
(TBS^CHAPS bu¡er; two times with 15 ml and three times with 1.5 ml),
for 10 min at 30‡C with gentle agitation. Cell pellets were boiled 5 min
in sample bu¡er. Solubilized proteins were electrophoresed on 8 and
15% SDS-PAGE and transferred onto Protran membranes.
2.6. Pull-down experiments
Pull-down experiments were performed as described previously [3]
with modi¢cation. Brie£y, 200 pmol of GST^caveolin-1 or of GST
were bound to 30 Wl of glutathione^Sepharose 4B beads. Washed
beads were incubated, with gentle agitation, overnight at 30‡C with
300 Wl of CHAPS fractions or 300 Wl of cytosolic fractions, or for 5 h
at 30‡C with 150 Wl of a 0.2 WM striatin 1^427 solution prepared in
TBS^CHAPS bu¡er. After four washes in 1.5 ml TBS^CHAPS bu¡er
for 10 min at 30‡C, beads were treated as described above. To quan-
tify the amounts of striatin pulled down in the presence (0.1 mM) or
absence of Ca2 (1 mM EGTA), densitometric analysis of the immu-
noreactive bands was achieved using a specially designed software
(NIH Image 1.59).
3. Results
3.1. Anti-caveolin-1 antibodies co-immunoprecipitate rat brain
striatin, SG2NA and zinedin
Brain caveolin-1 was e⁄ciently solubilized by the zwitter-
ionic detergent CHAPS, provided that a rather high ionic
strength bu¡er, containing 500 mM NaCl, was used. Upon
fractionation of brain homogenate, striatin, SG2NA and zi-
nedin partitioned in both cytosol and CHAPS fractions (Fig.
1A^C, lane 1), whereas caveolin-1 was present only in the
CHAPS fraction (Fig. 1D, lane 1). We looked for a possible
association between caveolin-1 and rat brain striatin, SG2NA
and zinedin by co-immunoprecipitation experiments using
Fig. 1. Striatin, SG2NA and zinedin are co-immunoprecipitated
with caveolin-1. A^D: PS cells, coated with anti-caveolin-1 antibod-
ies (lane 2) or pre-immune immunoglobulins (lane 3), were incu-
bated with CHAPS fractions (lane 1). The washed pellets were ana-
lyzed by Western blots using anti-striatin (A), anti-SG2NA (B) or
anti-zinedin (C) a⁄nity-puri¢ed antibodies, or anti-caveolin-1 anti-
bodies (D). The ECL procedure for caveolin, and the alkaline phos-
phatase procedure, for striatin, SG2NA and zinedin were used. The
apparent molecular weight (kDa) of the revealed proteins are indi-
cated on the right (arrows). E: Caveolin-1 is co-immunoprecipitated
with the three members of the striatin family. PS cells coated with
anti-striatin (lane 2), anti-SG2NA (lane 3), anti-zinedin (lane 4) af-
¢nity-puri¢ed antibodies or pre-immune immunoglobulins (lane 5)
were incubated with CHAPS fractions (lane 1). The washed pellets
were analyzed by Western blots using anti-caveolin-1 antibodies and
the alkaline phosphatase procedure. The apparent molecular weight
of caveolin-1 is indicated on the right (arrow).
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CHAPS fractions and anti-caveolin-1 antibodies. Analysis of
immunoprecipitates showed that striatin (Fig. 1A, lane 2), the
isoforms of SG2NA (Fig. 1B, lane 2) and zinedin (Fig. 1C,
lane 2) were co-immunoprecipitated along with caveolin-1
(Fig. 1D, lane 2) but were not present in immunoprecipitates
obtained with control antibodies (Fig. 1, lane 3). Anti-striatin
(Fig. 1E, lane 2), anti-SG2NA (Fig. 1E, lane 3) and anti-zi-
nedin antibodies (Fig. 1E, lane 4) all co-immunoprecipitated
caveolin-1 present in rat brain CHAPS fractions (Fig. 1E, lane
1).
3.2. GST^caveolin-1 pulls down rat brain striatin, SG2NA and
zinedin
To further document the fact that rat brain striatin,
SG2NA and zinedin interact with caveolin-1, we performed
pull-down experiments using GST^caveolin-1 and CHAPS
fractions. Rat brain striatin present in a CHAPS fraction
(Fig. 2A, lane 1) or in a cytosol fraction (Fig. 2A, lane 4)
speci¢cally bound GST^caveolin-1 (Fig. 2A, lanes 2 and 5)
but not GST (Fig. 2A, lanes 3 and 6). More striatin was
pulled down when incubation took place at 30‡C rather
than 4‡C. Interestingly, about 50 þ 10% less striatin (mean
of three independent determinations) was pulled down by
GST^caveolin-1 from Ca2- (Fig. 3, lane 4) rather than
from EGTA-containing CHAPS fractions (Fig. 3, lane 3).
Rat brain SG2NA (Fig. 2B, lane 2) and zinedin (Fig. 2C,
lane 2) also bound GST^caveolin-1 but did not bind GST
(Fig. 2B,C, lane 3).
3.3. Recombinant caveolin-1 and striatin physically interact
The latter experiments do not indicate whether the interac-
tions between caveolin-1 and rat brain striatin, SG2NA and
zinedin are direct. To check this point, we puri¢ed a fragment
of recombinant striatin containing the putative caveolin-bind-
ing domain, striatin 1^427 (Fig. 4, lane 1). Incubation of this
fragment with GST^caveolin-1 and with GST showed that it
speci¢cally bound GST^caveolin-1 (Fig. 4, lane 2) but not
GST (Fig. 4, lane 3).
4. Discussion
Caveolins have been reported to interact with an amazingly
large number of signalling proteins [8]. Proteins for which a
direct interaction with the sca¡olding domain of caveolins has
been demonstrated are fewer: endothelial and neuronal nitric
oxide synthases [17,18], Ras [13], G protein-coupled receptor
kinases 1, 2 and 5 [10], p75NTR [19], the androgen receptor
[20]. The present study shows that striatin, SG2NA and zine-
din all interact in vitro with caveolin-1, and that in the case of
striatin, at least, they physically interact.
It has been only recently demonstrated that caveolin-1 and -
2 are expressed in neurons [14]. Here, we have shown that
brain caveolin-1 can be e⁄ciently solubilized by CHAPS. To
examine possible interactions between caveolin-1 and the pro-
teins of the striatin family, we did not need to overexpress
striatin, SG2NA or zinedin, since their amounts in brain frac-
tions proved to be su⁄cient. To our knowledge, proteins of
the striatin family are not modi¢ed by lipids. Many of the
signalling proteins that interact with caveolin are known to
be post-translationally modi¢ed by lipids [21^23]. However, in
vitro studies have shown that such modi¢cations are not a
prerequisite for binding to caveolins [13].
Since pull-down experiments using GST^caveolin-1 and a
fragment of striatin containing the caveolin-binding motif
showed that the interaction of the two proteins is direct,
and since the caveolin-binding motifs of SG2NA and zinedin
are 100% similar to that of striatin, it is likely that the inter-
action of caveolin with SG2NA or zinedin is also direct. Be-
cause the caveolin-binding domain of the proteins of the stria-
tin family is contiguous with the putative coiled-coil structure,
a possibility would be that binding of caveolin-1 in£uences the
state of this structure.
We have previously shown that the distribution of striatin
Fig. 2. GST^caveolin-1 pulls down endogenous rat brain striatin,
SG2NA and zinedin. GST^caveolin-1-coated beads (lanes 2 and 5)
and GST-coated beads (lanes 3 and 6) were incubated at 30‡C with
a CHAPS fraction (lanes 1^3) or a cytosol fraction (lanes 4^6).
Washed beads were analyzed by Western blots using anti-striatin
(A), anti-SG2NA (B) or anti-zinedin (C) a⁄nity-puri¢ed antibodies.
The ECL procedure, for striatin, and the alkaline phosphatase pro-
cedure, for SG2NA and zinedin were used. Apparent molecular
weight of striatin, SG2NA isoforms and zinedin are indicated on
the right (arrows).
Fig. 3. The presence of free Ca2 (0.1 mM) in CHAPS fractions
(lane 2) decreases the interaction of striatin with GST^caveolin-1, as
compared to EGTA-containing CHAPS fractions (lane 1). GST^
caveolin-1 pulls down 50% less striatin from Ca2-containing
CHAPS fractions (lane 4) than from EGTA-containing fractions
(lane 3). The apparent molecular weight of striatin is indicated. The
asterisk shows non-speci¢c staining of a protein irrelevant to stria-
tin.
Fig. 4. Striatin directly interacts with caveolin-1. Washed GST^ca-
veolin-1-coated beads (lane 2) and GST-coated beads (lane 3) were
incubated with recombinant striatin 1^427 (lane 1) and analyzed by
Western blots using anti-striatin a⁄nity-puri¢ed antibodies. The
ECL procedure was used. The apparent molecular weight of striatin
1^427 is indicated on the right (arrow).
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varies upon fractionation of brain homogenates according to
their Ca2 concentration: about twice as much striatin was
found in the cytosol fraction from Ca2-containing homoge-
nates than from EGTA-containing homogenates [6]. That the
proteins of the striatin family also shift from membranes to
cytosol according to local Ca2 £uctuations in vivo is a likely
hypothesis. In that case, at least some of their partners should
change. Our ¢nding that recombinant caveolin-1 pulls down
less striatin in the presence of Ca2 than in its absence may be
relevant to the previous observation. Caveolae are hypothe-
sized to be subcellular domains that regulate intracellular
Ca2 concentration and Ca2-dependent signal transduction
[24]. The addressing of striatin to such caveolin-rich domains
would possibly modulate the occupancy of their Ca2^cal-
modulin-binding domain and hence their subcellular localiza-
tion.
Caveolins are known to interact with signalling proteins.
The present study thus comforts our hypothesis concerning
a possible signalling role for the proteins of the striatin family.
Some tyrosine kinases, Ras, GK, eNOS, interact with caveolin
in their inactive form [11^13,17]. On the contrary, the binding
of the androgen receptor to caveolin results in its enhanced
activation [20]. Although the e¡ects of striatin down-regula-
tion are major [2], the molecular roles of the proteins of the
striatin family are not yet known. However, besides caveolin,
some of their partners are known: calmodulin and phocein.
Phocein, a major partner of the proteins of the striatin family,
is most probably involved in vesicular tra⁄c [3]. As many
cytosolic proteins are now known to play dual roles in endo-
cytic processes as well as in signalling [25], it is likely that the
proteins of the striatin family, bearing both a calmodulin-
binding site and a WD-repeat, sca¡olding domain, function
in both processes.
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